Oral administration of PEITC reduces food intake during refeeding following fasting. by Miho Yagi (5921252)

Oral administration of PEITC stimulates leptin signaling in the hypothalamus. by Miho Yagi (5921252)

Agar diffusion antimicrobial assay of a recombinant <i>Lv</i>Lyz-c. by Nutthapon Sangklai (18462533)

PEITC induces nuclear accumulation of p-STAT3 and regulates its target gene expression in differentiated SH-SY5Y cells. by Miho Yagi (5921252)

Averaged first slice of second-order kernel of the mfERGs of the nasal hemisphere within the central 7.5° for different stages of glaucoma (Blue trace: Advanced stage, Brown trace:... by Naoya Moroto (14419705)

Results of the statistical tests (in terms of means and p values) performed over the fitted parameters capturing the effect of self-motion on different dependent variables. by Björn Jörges (9258411)

Htt-exon1(46Q) fibrils seed aggregation in a <i>C</i>. <i>elegans</i> strain (EAK102) expressing a non-pathogenic N-terminal htt fragment [htt-513(Q15)]. by Adam Skeens (18156026)

FITC inhibits PTP1B by binding to cysteinyl thiol. by Miho Yagi (5921252)

Cell count of PC-3, Adcarc1258 and LNCaP after application of FX-9, A: Azacitidine and B: Carboplatin and both agents in combination. by Franziska Weiner (11331042)

Periphyton stoichiometry from all three lakes. by Beth C. Norman (754890)

PI3K-C2α knockdown inhibits sustained autophagy and results in the formation of lipid droplets. by Nathan M. Merrill (4437367)

Main characteristics of the included trials. by Yuan-yuan WANG (19370071)

“…The mean glucose level was significantly decreased by HCL (<i>p</i> <0.001; <i>I</i>² = 58%), however, no significant difference was found in coefficient of variation of sensor glucose (<i>p</i> = 0.82; <i>I</i>² = 71%) and daily insulin dose (<i>p</i> = 0.94; <i>I</i>² <0.001) between the HCL group and the control group.…”

Distribution of the AOM-FS and AOM-SOS (version 4) symptom scores by days since enrolment into trial. by Penelope Abbott (3502094)

Responsiveness of AOM-FS and AOM-SOS (version 4) symptom scales to clinical changes by days after enrolment to trial. by Penelope Abbott (3502094)

Baseline characteristics. by Daniela Sánchez-Santiesteban (21192342)

“…Lower income levels are associated with decreased survival, potentially due to delays in diagnosis or treatment and a higher probability of advanced staging at diagnosis, These inequities persist even among relatively advantaged populations, such as formal employee who are assumed to have fewer barriers to accessing healthcare services compared to informal workers.…”

Correlation and principal component analysis. by Jie Wei (264772)

Example of sample data. by Xiying Wang (4859998)

“…The results reveal that as the number of nodes in the hidden layer increases, the model’s Mean Squared Error (MSE) and Relative Error (RE) show a decreasing trend, indicating an improvement in model prediction accuracy. …”

Structure of BPNN. by Xiying Wang (4859998)

“…The results reveal that as the number of nodes in the hidden layer increases, the model’s Mean Squared Error (MSE) and Relative Error (RE) show a decreasing trend, indicating an improvement in model prediction accuracy. …”

The workflow of EGA-BPNN. by Xiying Wang (4859998)

“…The results reveal that as the number of nodes in the hidden layer increases, the model’s Mean Squared Error (MSE) and Relative Error (RE) show a decreasing trend, indicating an improvement in model prediction accuracy. …”

S1 Data - by Xiying Wang (4859998)

“…The results reveal that as the number of nodes in the hidden layer increases, the model’s Mean Squared Error (MSE) and Relative Error (RE) show a decreasing trend, indicating an improvement in model prediction accuracy. …”